Eliminating Hepatitis C in the United States

Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and is associated with gait impairment, cognitive decline, and urinary dysfunction. Author Mark G. Luciano, MD, PhD, from Johns Hopkins University, discusses this and ...  Show more

Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs can reduce inflammation and lower the risk of joint destruction. JAMA Associate Editor David Simel, MD, MHS, is joined by review coauthor Josef Smolen, ...  Show more

Learn what Hepatitis C is, who is at risk of contracting it, and how it is treated. Read the full transcript here: http://bit.ly/1hHvQy6 Hosted on Acast. See acast.com/privacy for more information. 

Guest: John J. Poterucha, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD) 

The topic of Hepatitis C, including risk factors, evaluation and management was discussed with Dr. John Poterucha, a gastroenterologist from the Di ...

This week, we’re dipping a toe back into the vast waters of hepatitis viruses, this time with a focus on hepatitis B. The hepatitis B virus, though second to be named, was first to be discovered, and effective vaccines and treatments have been available for decades. Yet the gl ...

In this episode, hosts Drs. Jennifer Lee and Jason Silverman talk to Dr. Norberto Rodriguez-Baez about Hepatitis ...